Simon Lovestone, PhD, MRCPsych

Old Age Psychiatry King's College London, London, UK 
"Simon Lovestone"

Cross-listing: Neurotree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Neumann A, Ohlei O, Küçükali F, et al. (2023) Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning. Genome Medicine. 15: 79
Shi L, Xu J, Green R, et al. (2023) Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Maruszak A, Silajdžić E, Lee H, et al. (2023) Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum. Brain : a Journal of Neurology
Küçükali F, Neumann A, Van Dongen J, et al. (2022) Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Ng B, Rowland HA, Wei T, et al. (2022) Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability. Brain Communications. 4: fcac267
Foster EM, Fernandes M, Dangla-Valls A, et al. (2022) Glycosylated clusterin species facilitate Aβ toxicity in human neurons. Scientific Reports. 12: 18639
Delvenne A, Gobom J, Tijms B, et al. (2022) Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Wesenhagen KEJ, Gobom J, Bos I, et al. (2022) Effects of age, amyloid, sex, and ε4 on the CSF proteome in normal cognition. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12286
Visser PJ, Reus LM, Gobom J, et al. (2022) Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease. Molecular Neurodegeneration. 17: 37
Hillary RF, Gadd DA, McCartney DL, et al. (2022) Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12280
See more...